FMS样酪氨酸激酶3配体(Flt3L)重组蛋白
Recombinant FMS Like Tyrosine Kinase 3 Ligand (Flt3L)
FOR IN VITRO AND RESEARCH USE ONLY, NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES!
Organism species
|
Homo sapiens (Human)
|
Product No.
|
KL038Hu01
|
Source
|
Prokaryotic expression
|
Host
|
E.coli
|
Purity
|
> 95%
|
UOM
|
50ug
|
Predicted Molecular Mass
|
25.2kDa
|
Concentration
|
n/a
|
Applications
|
SDS-PAGE; WB; ELISA; IP.
|
Endotoxin Level
|
<1.0EU per 1µg (determined by the LAL method)
|
Residues
|
Thr27~His235 (Accession # P49771) with N-terminal His-Tag
|
Formulation
|
Supplied as lyophilized form in PBS, pH7.4, containing 5% trehalose, 0.01% sarcosyl.
|
FMS样酪氨酸激酶3配体(Flt3L)重组蛋白SEQUENCES
The sequence of the target protein is listed below.
MGHHHHHHSGSEF-TQDC SFQHSPISSD FAVKIRELSD YLLQDYPVTV ASNLQDEELC GGLWRLVLAQ RWMERLKTVA GSKMQGLLER VNTEIHFVTK CAFQPPPSCL RFVQTNISRL LQETSEQLVA LKPWITRQNF SRCLELQCQP DSSTLPPPWS PRPLEATAPT APQPPLLLLL LLPVGLLLLA AAWCLHWQRT RRRTPRPGEQ VPPVPSPQDL LLVEH
FMS样酪氨酸激酶3配体(Flt3L)重组蛋白USAGE
Reconstitute in sterile ddH2O.
FMS样酪氨酸激酶3配体(Flt3L)重组蛋白STORAGE AND STABILITY
Storage: Avoid repeated freeze/thaw cycles. Store at 2-8oC for one month. Aliquot and store at -80oC for 12 months.
Stability Test: The thermal stability is described by the loss rate of the target protein. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37oC for 48h, and no obvious degradation and precipitation were observed. (Referring from China Biological Products Standard, which was calculated by the Arrhenius equation.) The loss of this protein is less than 5% within the expiration date under appropriate storage condition.
FMS样酪氨酸激酶3配体(Flt3L)重组蛋白About the MARKER (complimentary)
Effective Size Range: 10kDa to 70kDa.
Protein bands: 10kDa, 14kDa, 18kDa, 22kDa, 26kDa, 33kDa, 44kDa and 70kDa.
Double intensity bands: The 26kDa, 18kDa, 10kDa bands are at double intensity to make location and size approximation of proteins of interest quick and easy.
Ready-to-use: No need to heat, dilute or add reducing agents before use.
KL644Hu02 白介素17受体A(IL17RA)重组蛋白 Recombinant Interleukin 17 Receptor A (IL17RA) Homo sapiens (Human)
KL349Hu01 白介素17受体D(IL17RD)重组蛋白 Recombinant Interleukin 17 Receptor D (IL17RD) Homo sapiens (Human)
KL821Hu01 白介素18结合蛋白(IL18BP)重组蛋白 Recombinant Interleukin 18 Binding Protein (IL18BP) Homo sapiens (Human)
KL146Hu01 脂质运载蛋白6(LCN6)重组蛋白 Recombinant Lipocalin 6 (LCN6) Homo sapiens (Human)
KL175Hu02 左右决定因子1(LEFTY1)重组蛋白 Recombinant Left/Right Determination Factor 1 (LEFTY1) Homo sapiens (Human)
KL358Hu02 丛状蛋白B1(PLXNB1)重组蛋白 Recombinant Plexin B1 (PLXNB1) Homo sapiens (Human)
KL323Hu01 黑色素瘤优先表达抗原(PRAME)重组蛋白 Recombinant Preferentially Expressed Antigen In Melanoma (PRAME) Homo sapiens (Human)
KL323Hu02 黑色素瘤优先表达抗原(PRAME)重组蛋白 Recombinant Preferentially Expressed Antigen In Melanoma (PRAME) Homo sapiens (Human)
KL757Hu02 过氧化还原酶2(PRDX2)重组蛋白 Recombinant Peroxiredoxin 2 (PRDX2) Homo sapiens (Human)
KL665Hu01 核糖核酸酶A13(RNASE13)重组蛋白 Recombinant Ribonuclease A13 (RNASE13) Homo sapiens (Human)